Disclose bio-safety data of under-test GM mustard: CIC

Image
Press Trust of India New Delhi
Last Updated : Apr 06 2016 | 9:02 PM IST
The Central Information Commission has directed the environment ministry to share a copy of the bio-safety document related to genetically-modified mustard and the raw data of studies with the caveat that provisions of the Cartagena Protocol on Biosafety as well as confidentiality should be kept in mind.
The transparency panel also directed that the entire bio- safety data pertaining to all other genetically modified crops in the pipeline be put in the public domain as that is part of voluntary disclosures under Section IV of the RTI Act.
The ministry had objected to the disclosure of the data, saying the information is exempted under the RTI clause related to commercial confidence of the third party -- the Centre for Genetic Manipulation of Crop Plants.
(REOPENS DEL63)
Information Commissioner Sridhar Acharyulu said people should know how and why GM mustard is being permitted or denied because they have to consume the item.
"All documents relating to GEAC recommendation, sub- committee report, revised dossier as recommended and to prepare RARM need to be furnished to the public in general in public interest. Its denial to appellant is not legal," Acharyulu said.
He directed that the environment ministry furnish the certified copy of the Technical Expert Committee (TEC) report and the joint affidavit filed by it and the agriculture ministry in response to the report.
The commissioner said even if the ministry claims exception under Section 8(1)(d), they have to justify the same by substantiating as to how it will breach the commercial confidence of the third party. It added that if so, they can separate the same and give the rest of the information to the appellant.
Terming it information of "public interest", Acharyulu said the ministry should understand that the information sought is supposed to be disclosed on their own as per the mandate under Section 4 of the RTI Act.
"It is a policy decision by the public authority which needs to be revealed to the public in general as mandated by Section 4 because they are going to be affected if GM mustard is marked," he said.
The Information Commissioner said it is quite clear that genetically engineered organisms or cells are recognised by the government as an item potentially hazardous to public health.
It automatically follows that full compliance with these rules is a matter of public interest.
"The decision-making process should be told along with information about whether such process is adopted, minutes of the meetings, results of clinical trial, and entire information about GM mustard etc. This is in public interest," Acharyulu said.
The order came on an RTI plea by Kavitha Kuruganthi, who had sought a copy of the bio-safety document of GM Mustard that is being experimented in fields for trial in India along with raw data of studies conducted.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 06 2016 | 9:02 PM IST

Next Story